Actualisation de la définition des infections nosocomiales [Internet] Disponible sur: http://solidarites-sante.gouv.fr/IMG/pdf/rapport_complet.pdf 2. SPILF. Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires de l'adulte, 2007. ,
The Paradigm Shift to Non-Treatment of Asymptomatic Bacteriuria. Pathogens, 2016. ,
Optimizing antibiotics in residents of nursing homes: protocol of a randomized trial, BMC Health Services Research, vol.14, issue.1, p.17, 2002. ,
DOI : 10.1093/ije/14.2.322
The Antibiotic Prescribing Pathway for Presumed Urinary Tract Infections in Nursing Home Residents, Journal of the American Geriatrics Society, vol.77, issue.58, 2017. ,
DOI : 10.1093/cid/ciw118
Antibiotic use in ontario facilities that provide chronic care, Journal of General Internal Medicine, vol.341, issue.6, p.37683, 2001. ,
DOI : 10.1056/NEJM199907223410403
Asymptomatic Significant Bacteriuria in the Non-pregnant Woman, Br Med J. 29 mars, vol.1, issue.5647, p.8046, 1969. ,
Antibiotics for asymptomatic bacteriuria, Cochrane Database Syst Rev. 8 avr, vol.4, p.9534, 2015. ,
The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?, Clin Infect Dis Off Publ Infect Dis Soc Am. sept, vol.55, issue.6, p.7717, 2012. ,
Asymptomatic Bacteriuria Treatment Is Associated With a Higher Prevalence of Antibiotic Resistant Strains in Women With Urinary Tract Infections, Clinical Infectious Diseases, 2015. ,
DOI : 10.1093/cid/civ696
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases, Clin Infect Dis. 1 mars, vol.52, issue.5, p.10320, 2011. ,
Evaluation of New Anti-Infective Drugs for the Treatment of Urinary Tract Infection, Clinical Infectious Diseases, vol.15, issue.Supplement_1, p.21627, 1992. ,
DOI : 10.1093/clind/15.Supplement_1.S216
Community-Onset Escherichia coli Infection Resistant to Expanded-Spectrum Cephalosporins in Low-Prevalence Countries, Antimicrobial Agents and Chemotherapy, vol.58, issue.4, p.212634, 2014. ,
DOI : 10.1128/AAC.02052-13
Antimicrobial Resistance in Urinary Tract Pathogens in Canada from, Antimicrob Agents Chemother. juill, vol.55, issue.7, p.316975, 2007. ,
Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department, International Journal of Infectious Diseases, vol.23, p.813, 2014. ,
DOI : 10.1016/j.ijid.2013.12.021
Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system, International Journal of Antimicrobial Agents, vol.38, p.6470, 2011. ,
DOI : 10.1016/j.ijantimicag.2011.09.009
Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: A meta-analysis of randomized controlled trials, Journal of Infection, vol.58, issue.2, p.91102, 2009. ,
DOI : 10.1016/j.jinf.2008.12.009
Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women, Br J Gen Pract. sept, vol.52, issue.482, p.72934, 2002. ,
The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study, Scandinavian Journal of Infectious Diseases, vol.17, issue.231, p.296301, 2004. ,
DOI : 10.2165/00003495-199100424-00005
Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - Results of a randomized controlled pilot trial, BMC Medicine, vol.13, issue.Suppl A, p.30, 2010. ,
DOI : 10.3310/hta13190
Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial, BMJ, vol.340, issue.feb05 1, 2010. ,
DOI : 10.1136/bmj.c199
Women with symptoms of uncomplicated urinary tract infection are often willing to delay antibiotic treatment: a prospective cohort study, BMC Family Practice, vol.12, issue.1, p.71, 2013. ,
DOI : 10.1186/1471-2334-12-146
Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. The BMJ. 23 déc 2015 ,
Epidemiology of urinary tract infections: incidence, morbidity, and economic costs, The American Journal of Medicine, vol.113, issue.1, pp.5-13, 2002. ,
DOI : 10.1016/S0002-9343(02)01054-9
Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study, Infection, vol.5, issue.1, p.3340, 2017. ,
DOI : 10.1586/14737167.5.4.457
URL : https://hal.archives-ouvertes.fr/hal-01324986
Urologic Disease Burden in the United States: Veteran Users of Department of Veterans Affairs Healthcare, Urology, vol.72, issue.1, p.3741, 2008. ,
DOI : 10.1016/j.urology.2007.11.163
Quality of Life in Women With Urinary Tract Infections: Is Benign Disease a Misnomer?, The Journal of the American Board of Family Medicine, vol.13, issue.6, p.3927, 2000. ,
DOI : 10.3122/15572625-13-6-392
Urinary Tract Infection Syndromes, Infectious Disease Clinics of North America, vol.28, issue.1, p.113, 2014. ,
DOI : 10.1016/j.idc.2013.09.003
Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costs, Expert Review of Pharmacoeconomics & Outcomes Research, vol.15, issue.4, p.45766, 2005. ,
DOI : 10.1016/0732-8893(92)90136-H
Guidelines for the diagnosis and management of recurrent urinary tract infection in women, Can Urol Assoc J. 1 oct, p.31622, 2011. ,
Treatment of uncomplicated urinary tract infection in non-pregnant women, Postgraduate Medical Journal, vol.48, issue.556, p.6975, 1972. ,
DOI : 10.1136/pgmj.48.556.69
Uncomplicated Urinary Tract Infection, New England Journal of Medicine, vol.366, issue.11, p.102837, 2012. ,
DOI : 10.1056/NEJMcp1104429
Risk Factors for Recurrent Urinary Tract Infection in Young Women, The Journal of Infectious Diseases, vol.182, issue.4, p.117782, 2000. ,
DOI : 10.1086/315827
Residual Urine in an Elderly Female Population: Novel Implications for Oral Estrogen Replacement and Impact on Recurrent Urinary Tract Infection, The Journal of Urology, vol.171, issue.2, 2004. ,
DOI : 10.1097/01.ju.0000107261.64927.b3
Recurrent Urinary Tract Infections in Postmenopausal Women, Clinical Infectious Diseases, vol.30, issue.1, p.1526, 2000. ,
DOI : 10.1086/313596
Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women, PLoS ONE, vol.4, issue.6, p.5990, 2009. ,
DOI : 10.1371/journal.pone.0005990.s002
Inverse Association of H2O2-Producing Lactobacilli and Vaginal Escherichia coli Colonization in Women with Recurrent Urinary Tract Infections, Journal of Infectious Diseases, vol.178, issue.2, p.44650, 1998. ,
DOI : 10.1086/515635
Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections, Science, vol.301, issue.5629, p.1057, 2003. ,
DOI : 10.1126/science.1084550
Population Dynamics and Niche Distribution of Uropathogenic Escherichia coli during Acute and Chronic Urinary Tract Infection, Infection and Immunity, vol.79, issue.10, p.42509, 2011. ,
DOI : 10.1128/IAI.05339-11
Genomic Diversity and Fitness of E. coli Strains Recovered from the Intestinal and Urinary Tracts of Women with Recurrent Urinary Tract Infection, Science Translational Medicine, vol.103, issue.15, pp.184-60, 2013. ,
DOI : 10.1073/pnas.0600938103
Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection, PLoS Medicine, vol.265, issue.12, p.329, 2007. ,
DOI : 10.1371/journal.pmed.0040329.t002
Intracellular Bacteria in the Pathogenesis of Escherichia coli Urinary Tract Infection in Children, Clinical Infectious Diseases, vol.59, issue.11, p.15864, 2014. ,
DOI : 10.1093/cid/ciu634
Pulsed-Field Gel Electrophoresis Typing of Escherichia coli Strains from Samples Collected before and after Pivmecillinam or Placebo Treatment of Uncomplicated Community-Acquired Urinary Tract Infection in Women, Journal of Clinical Microbiology, vol.44, issue.5, p.177681, 2006. ,
DOI : 10.1128/JCM.44.5.1776-1781.2006
Prospective Cohort Study of Microbial and Inflammatory Events Immediately Preceding Escherichia coli Recurrent Urinary Tract Infection in Women, J Infect Dis. 1 août, vol.200, issue.4, p.52836, 2009. ,
Recurrence of Urinary Tract Infection in a Primary Care Setting: Analysis of a I-Year Follow-up of 179 Women, Clinical Infectious Diseases, vol.22, issue.1, p.919, 1996. ,
DOI : 10.1093/clinids/22.1.91
Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice, Journal of Antimicrobial Chemotherapy, vol.55, issue.3, p.3836, 2005. ,
DOI : 10.1093/jac/dki002
Persistence of Uropathogenic Escherichia coli in the Face of Multiple Antibiotics, Antimicrobial Agents and Chemotherapy, vol.54, issue.5, p.185563, 2010. ,
DOI : 10.1128/AAC.00014-10
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial, The Lancet Infectious Diseases, vol.17, issue.5, p.52837, 2017. ,
DOI : 10.1016/S1473-3099(17)30108-1
Rare Emergence of Symptoms during Long-Term Asymptomatic Escherichia coli 83972 Carriage without an Altered Virulence Factor Repertoire, The Journal of Urology, vol.191, issue.2, p.51928, 2014. ,
DOI : 10.1016/j.juro.2013.07.060
Population-Based Epidemiologic Analysis of Acute Pyelonephritis, Clinical Infectious Diseases, vol.45, issue.3, p.27380, 2007. ,
DOI : 10.1086/519268
The Epidemiology of Acute Pyelonephritis in South Korea, 1997-1999, American Journal of Epidemiology, vol.160, issue.10, p.98593, 2004. ,
DOI : 10.1093/aje/kwh308
A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis, The Korean Journal of Internal Medicine, vol.30, issue.3, p.37283, 2015. ,
DOI : 10.3904/kjim.2015.30.3.372
Epidemiology and prognostic determinants of bacteremic acute pyelonephritis in women, Journal of Infection, vol.66, issue.2, p.1936, 2013. ,
DOI : 10.1016/j.jinf.2012.10.015
Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis, Journal of Infection, vol.62, issue.2, p.15964, 2011. ,
DOI : 10.1016/j.jinf.2010.10.009
Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER, Journal of Infection and Chemotherapy, vol.18, issue.1, p.1303, 2012. ,
DOI : 10.1007/s10156-011-0289-z
Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment, Journal of Infection, vol.60, issue.2, p.11421, 2010. ,
DOI : 10.1016/j.jinf.2009.11.008
Acute Pyelonephritis in Adults, Archives of Internal Medicine, vol.163, issue.10, p.120612, 2003. ,
DOI : 10.1001/archinte.163.10.1206
???Collateral Damage??? from Cephalosporin or Quinolone Antibiotic Therapy, Clinical Infectious Diseases, vol.38, issue.Supplement_4, p.3415, 2004. ,
DOI : 10.1086/382690
URL : https://academic.oup.com/cid/article-pdf/38/Supplement_4/S341/789031/38-Supplement_4-S341.pdf
Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis, BMJ, vol.340, issue.may18 2, pp.2096-2096, 0182. ,
DOI : 10.1136/bmj.c2096
Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model, Journal of Antimicrobial Chemotherapy, vol.67, issue.10, p.252330, 2012. ,
DOI : 10.1093/jac/dks222
Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance, American Journal of Infection Control, vol.43, issue.9, 2015. ,
DOI : 10.1016/j.ajic.2015.05.033
Évolution des recommandations pour la prise en charge des infections urinaires communautaires de l'adulte. 18es Journées Nationales d'Infectiologie (JNI); 2017 juin ,
Community-onset Urinary Tract Infections: A Population-based Assessment, Infection, vol.35, issue.3, p.150, 2007. ,
DOI : 10.1007/s15010-007-6180-2
UROLOGIC DISEASES IN AMERICA PROJECT: TRENDS IN RESOURCE USE FOR URINARY TRACT INFECTIONS IN MEN, The Journal of Urology, vol.173, issue.4, p.128894, 2005. ,
DOI : 10.1097/01.ju.0000155595.98120.8e
Acute Pyelonephritis in US Hospitals in 1997, Annals of Epidemiology, vol.13, issue.2, p.14450, 2003. ,
DOI : 10.1016/S1047-2797(02)00272-7
Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis, BMC Infectious Diseases, vol.11, issue.Suppl 3, 2008. ,
DOI : 10.1016/S0733-8627(05)70210-8
Penetration of Antimicrobial Agents into the Prostate, Chemotherapy, vol.49, issue.6, p.26979, 2003. ,
DOI : 10.1159/000074526
Clinical characteristics and outcomes of adenovirus infection of the urinary tract after renal transplantation, Transplant Infectious Disease, vol.18, issue.5, p.2349, 2016. ,
DOI : 10.1016/j.bbmt.2011.09.007
Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients, The Lancet Infectious Diseases, vol.3, issue.2, p.7986, 2003. ,
DOI : 10.1016/S1473-3099(03)00515-2
BK-virus infections: A literature review, M??decine et Maladies Infectieuses, vol.42, issue.5, p.1817, 2012. ,
DOI : 10.1016/j.medmal.2012.04.011
Uropathogen distribution and antimicrobial susceptibility in uncomplicated cystitis in Belgium, a high antibiotics prescribing country: 20-year surveillance, European Journal of Clinical Microbiology & Infectious Diseases, vol.10, issue.4, p.10513, 2017. ,
DOI : 10.1016/S0924-8579(98)00021-1
The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections, International Journal of Antimicrobial Agents, vol.34, issue.5, p.40713, 2009. ,
DOI : 10.1016/j.ijantimicag.2009.04.012
URL : https://hal.archives-ouvertes.fr/hal-00556347
Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006, International Journal of Antimicrobial Agents, vol.31, p.158, 2008. ,
DOI : 10.1016/j.ijantimicag.2007.07.043
Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs, The American Journal of Emergency Medicine, vol.30, issue.6, p.9429, 2012. ,
DOI : 10.1016/j.ajem.2011.05.008
Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran, International Journal of Infectious Diseases, vol.13, issue.2, p.1404, 2009. ,
DOI : 10.1016/j.ijid.2008.04.014
Inappropriate Empirical Treatment of Uncomplicated Cystitis in Thai Women: Lessons Learned, Clinical Infectious Diseases, vol.64, issue.suppl_2, p.1158, 2017. ,
DOI : 10.1093/cid/cix088
Prevalence and Risk Factor Analysis of Trimethoprim-Sulfamethoxazole? and Fluoroquinolone- Resistant Escherichia coli Infection among Emergency Department Patients with Pyelonephritis, Clin Infect Dis. 1 nov, vol.47, issue.9, p.11508, 2008. ,
Fluoroquinolone-Resistant and Extended-Spectrum ?-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, Emerg Infect Dis. sept, vol.22, issue.19, 2016. ,
When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data, Journal of Antimicrobial Chemotherapy, vol.58, issue.6, p.13036, 2006. ,
DOI : 10.1093/jac/dkl432
Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting, Clinical Microbiology and Infection, vol.17, issue.12, p.184551, 2011. ,
DOI : 10.1111/j.1469-0691.2011.03519.x
Evolution des fréquences d'isolement et de la résistance des souches d'Escherichia coli isolées d'infections urinaires en pratique de ville de, Médecine Mal Infect. 1 juin, vol.24, p.53942, 1986. ,
Les entérobactéries isolées d'infections urinaires en pratique de ville : étude AFORCOPIBIO 1995, Médecine Mal Infect. 1 juin, vol.27, p.6425, 1997. ,
Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group, Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. févr, vol.19, issue.2, p.1127, 2000. ,
Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO??SENS study revisited, International Journal of Antimicrobial Agents, vol.39, issue.1 ,
DOI : 10.1016/j.ijantimicag.2011.09.013
Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program, Diagn Microbiol Infect Dis. 1 avr, vol.45, issue.4, p.295301, 2000. ,
Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000???2009), BMC Infectious Diseases, vol.58, issue.1, p.19, 2000. ,
DOI : 10.1093/jac/dkl243
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: Rates and predicting factors, M??decine et Maladies Infectieuses, vol.44, issue.5, p.21722, 2014. ,
DOI : 10.1016/j.medmal.2014.03.003
Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in??community-onset urinary tract infections in France in 2013, Journal of Infection, vol.72, issue.2, p.2016, 2016. ,
DOI : 10.1016/j.jinf.2015.11.009
URL : https://hal.archives-ouvertes.fr/hal-01246265
The antibiotic resistome: the nexus of chemical and genetic diversity, Nature Reviews Microbiology, vol.78, issue.3, p.17586, 2007. ,
DOI : 10.7164/antibiotics.56.135
Origins and Evolution of Antibiotic Resistance, Microbiology and Molecular Biology Reviews, vol.74, issue.3, p.41733, 2010. ,
DOI : 10.1128/MMBR.00016-10
Ecology drives a global network of gene exchange connecting the human microbiome, Nature, vol.37, issue.7376, p.2414, 2011. ,
DOI : 10.1093/nar/gkn656
SOS response promotes horizontal dissemination of antibiotic resistance genes, Nature, vol.427, issue.6969, p.724, 2004. ,
DOI : 10.1038/nature02241
Selective pressure affects transfer and establishment of a Lactobacillus plantarum resistance plasmid in the gastrointestinal environment, Journal of Antimicrobial Chemotherapy, vol.61, issue.4, p.84552, 2008. ,
DOI : 10.1093/jac/dkn033
Resistance in bacteria of the food chain: epidemiology and control strategies, Expert Review of Anti-infective Therapy, vol.11, issue.5, p.73350, 2008. ,
DOI : 10.3201/eid1112.010977
Tackling drug-resistant infection globally: Final report and recommendations [Internet] ,
Community-onset extended-spectrum ??-lactamase (ESBL) producing Escherichia coli: Importance of international travel, Journal of Infection, vol.57, issue.6, p.4418, 2008. ,
DOI : 10.1016/j.jinf.2008.09.034
Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae, Clinical Infectious Diseases, vol.60, issue.6, p.83746, 2015. ,
DOI : 10.1093/cid/ciu957
Revised Estimates for the Number of Human and Bacteria Cells in the Body, PLOS Biology, vol.347, issue.8, p.1002533, 2016. ,
DOI : 10.1371/journal.pbio.1002533.s002
Gut microbiota and development of atopic eczema in 3 European birth cohorts, Journal of Allergy and Clinical Immunology, vol.120, issue.2, p.34350, 2007. ,
DOI : 10.1016/j.jaci.2007.05.018
Population-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections, Clinical Microbiology Reviews, vol.27, issue.4, p.64764, 2014. ,
DOI : 10.1016/S1473-3099(10)70143-2
Evolution of plasmid-coded resistance to broad-spectrum cephalosporins., Antimicrobial Agents and Chemotherapy, vol.28, issue.2, p.3027, 1985. ,
DOI : 10.1128/AAC.28.2.302
Growing Group of Extended-Spectrum ??-Lactamases: the CTX-M Enzymes, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, p.114, 2004. ,
DOI : 10.1128/AAC.48.1.1-14.2004
CTX-M Enzymes: Origin and Diffusion. Front Microbiol. 2 avr 2012 ,
Escherichia coli ST131, an Intriguing Clonal Group, Clinical Microbiology Reviews, vol.27, issue.3, p.54374, 2014. ,
DOI : 10.1128/CMR.00125-13
URL : https://hal.archives-ouvertes.fr/hal-01061609
Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls, Clinical Microbiology and Infection, vol.19, issue.4, p.17380, 2013. ,
DOI : 10.1111/1469-0691.12123
Phylogenetic Distribution of CTX-M- and Non-Extended-Spectrum-??-Lactamase-Producing Escherichia coli Isolates: Group B2 Isolates, Except Clone ST131, Rarely Produce CTX-M Enzymes, Journal of Clinical Microbiology, vol.50, issue.9, p.297481, 2012. ,
DOI : 10.1128/JCM.00919-12
Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications, Journal of Antimicrobial Chemotherapy, vol.69, issue.3, p.80914, 2014. ,
DOI : 10.1093/jac/dkt405
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace, The Journal of Infectious Diseases, vol.215, issue.suppl_1, p.2836, 2017. ,
DOI : 10.1093/infdis/jiw282
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum ??-lactamases: a systematic review and meta-analysis, Journal of Antimicrobial Chemotherapy, vol.67, issue.12, p.2793803, 2012. ,
DOI : 10.1093/jac/dks301
Temocillin revived, Journal of Antimicrobial Chemotherapy, vol.63, issue.2, p.2435, 2008. ,
DOI : 10.1093/jac/dkn511
URL : https://academic.oup.com/jac/article-pdf/63/2/243/2105205/dkn511.pdf
Molecular structures of penicillin-binding proteins and beta-lactamases, Trends Microbiol. oct, vol.2, issue.10, p.37280, 1994. ,
Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin, Microbiol Mol Biol Rev MMBR. déc, vol.62, issue.4, p.1371414, 1998. ,
Updated functional classification of beta-lactamases, Antimicrob Agents Chemother. mars, vol.54, issue.3, p.96976, 2010. ,
The structure of beta-lactamases, Philos Trans R Soc Lond B Biol Sci. 16 mai, vol.289, p.32131, 1036. ,
A functional classification scheme for betalactamases and its correlation with molecular structure, Antimicrob Agents Chemother. juin, vol.39, issue.6, p.121133, 1995. ,
BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans., Antimicrobial Agents and Chemotherapy, vol.20, issue.1, p.3846, 1981. ,
DOI : 10.1128/AAC.20.1.38
Affinity of temocillin for Escherichia coli K-12 penicillin-binding proteins., Antimicrobial Agents and Chemotherapy, vol.26, issue.3, pp.335-338, 1984. ,
DOI : 10.1128/AAC.26.3.335
Improved sensitivity in assays for binding of novel beta-lactam antibiotics to penicillin-binding proteins of Escherichia coli., Antimicrobial Agents and Chemotherapy, vol.31, issue.8, p.12713, 1987. ,
DOI : 10.1128/AAC.31.8.1271
Antibacterial activity and beta-lactamase stability of temocillin., Antimicrobial Agents and Chemotherapy, vol.22, issue.3, p.45360, 1982. ,
DOI : 10.1128/AAC.22.3.453
Antibacterial activity of temocillin, Drugs, vol.29, p.6773, 1985. ,
Bacteriostatic and Bactericidal Activity of Penicillins at Constant and Variable Concentrations, Drugs, vol.29, issue.Supplement 5, p.914, 1985. ,
DOI : 10.2165/00003495-198500295-00004
Comparative In Vitro Activities of Meropenem, Imipenem, Temocillin, Piperacillin, and Ceftazidime in Combination with Tobramycin, Rifampin, or Ciprofloxacin against Burkholderia cepacia Isolates from Patients with Cystic Fibrosis, Antimicrob Agents Chemother. 2 janv, vol.43, issue.2, p.2137, 1999. ,
In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria, J Cyst Fibros. 1 déc, vol.9, issue.6, p.4504, 2010. ,
In Vitro Activity of Temocillin against Clinical Isolates, Drugs, vol.29, issue.Supplement 5, p.18, 1985. ,
DOI : 10.2165/00003495-198500295-00003
In Vitro Activity of Temocillin Against Neisseria Gonorrhoeae Including Penicillinase-Producing Strains, Drugs, vol.29, issue.Supplement 5, p.1823, 1985. ,
DOI : 10.2165/00003495-198500295-00006
Temocillin: In vitro activity against 734 selected clinical isolates, including ??-lactamase-producing strains, Diagnostic Microbiology and Infectious Disease, vol.2, issue.1, p.5563, 1984. ,
DOI : 10.1016/0732-8893(84)90023-3
In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin., Antimicrobial Agents and Chemotherapy, vol.22, issue.1, p.15761, 1982. ,
DOI : 10.1128/AAC.22.1.157
Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis, Journal of Antimicrobial Chemotherapy, vol.67, issue.3, p.7715, 2012. ,
DOI : 10.1093/jac/dkr543
Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic, Scientific Reports, vol.8, p.40208, 2017. ,
DOI : 10.1371/journal.pone.0080514
-lactamases and mechanism-based inactivators: a kinetic study and an overview, Biochemical Journal, vol.295, issue.3, pp.705-711, 1993. ,
DOI : 10.1042/bj2950705
Outbreak of Klebsiella pneumoniae Producing a New Carbapenem- Hydrolyzing Class A ??-Lactamase, KPC-3, in a New York Medical Center, Antimicrobial Agents and Chemotherapy, vol.48, issue.12, p.47939, 2004. ,
DOI : 10.1128/AAC.48.12.4793-4799.2004
Alternatives to carbapenems in ESBL-producing Escherichia coli infections, M??decine et Maladies Infectieuses, vol.43, issue.2, p.626, 2013. ,
DOI : 10.1016/j.medmal.2013.01.006
URL : https://hal.archives-ouvertes.fr/hal-00802661
Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission, Diagnostic Microbiology and Infectious Disease, vol.87, issue.1 ,
DOI : 10.1016/j.diagmicrobio.2016.09.012
In vitro activity of temocillin against extended spectrum ??-lactamase-producing Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.57, issue.4, p.7714, 2006. ,
DOI : 10.1093/jac/dkl046
Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England, Journal of Antimicrobial Chemotherapy, vol.57, issue.5, p.10124, 2006. ,
DOI : 10.1093/jac/dkl043
In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units, European Journal of Clinical Microbiology & Infectious Diseases, vol.56, issue.Suppl. 5, p.77783, 2007. ,
DOI : 10.1179/acb.2001.044
Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.53, issue.6, p.27001, 2009. ,
DOI : 10.1128/AAC.00290-09
Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production, European Journal of Clinical Microbiology & Infectious Diseases, vol.51, issue.12, p.242937, 2015. ,
DOI : 10.1128/JCM.01634-13
The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway, Infect Dis Lond Engl. févr, vol.48, issue.2, p.99107, 2010. ,
Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15, J Antimicrob Chemother. mai, vol.70, issue.5, p.146672, 2015. ,
Pharmacokinetics of Temocillin in Volunteers, Drugs, vol.29, issue.Supplement 5, p.99102, 1985. ,
DOI : 10.2165/00003495-198500295-00020
Temocillin pharmacokinetics in normal and impaired renal function, Drugs, vol.29, p.1359, 1985. ,
activity and the pharmacokinetics and tissue penetration in healthy volunteers, Journal of Antimicrobial Chemotherapy, vol.10, issue.4, pp.295-302, 1982. ,
DOI : 10.1093/jac/10.4.295
Renal clearance of temocillin in volunteers, Drugs, vol.29, p.12834, 1985. ,
Effect of serum on the in vitro activities of 11 broad-spectrum antibiotics., Antimicrobial Agents and Chemotherapy, vol.34, issue.11, p.22349, 1990. ,
DOI : 10.1128/AAC.34.11.2234
Pharmacokinetics and Tissue Penetration of Temocillin, Drugs, vol.29, issue.Supplement 5, 1985. ,
DOI : 10.2165/00003495-198500295-00022
Penetration Of Temocillin Into Prostatic Tissue After Intravenous Dosing, Acta Clinica Belgica, vol.44, issue.5, p.3589, 1989. ,
DOI : 10.1080/17843286.1989.11718041
Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins, Diagnostic Microbiology and Infectious Disease, vol.22, issue.1-2, p.8996, 1995. ,
DOI : 10.1016/0732-8893(95)00053-D
DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current ??-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?, Clinical Infectious Diseases, vol.58, issue.8, p.107283, 2014. ,
DOI : 10.1093/cid/ciu027
Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPCproducing Escherichia coli, J Antimicrob Chemother. juill, vol.71, issue.7, p.1899904, 2016. ,
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection, Journal of Antimicrobial Chemotherapy, vol.61, issue.2, p.3828, 2008. ,
DOI : 10.1093/jac/dkm467
Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration, Journal of Antimicrobial Chemotherapy, vol.70, issue.3, p.8918, 2015. ,
DOI : 10.1093/jac/dku465
Influence of Temocillin on Human Bowel Flora, Drugs, vol.29, issue.Supplement 5, p.438, 1985. ,
DOI : 10.2165/00003495-198500295-00010
Studies with temocillin in a hamster model of antibiotic-associated colitis., Antimicrobial Agents and Chemotherapy, vol.27, issue.6, p.9801, 1985. ,
DOI : 10.1128/AAC.27.6.980
Clinical efficacy of temocillin, Journal of Antimicrobial Chemotherapy, vol.64, issue.2, p.4313, 2009. ,
DOI : 10.1093/jac/dkp208
Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC ??-lactamase-producing Enterobacteriaceae, Journal of Antimicrobial Chemotherapy, vol.66, issue.11, p.262831, 2011. ,
DOI : 10.1093/jac/dkr317
Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit, European Journal of Clinical Microbiology & Infectious Diseases, vol.45, issue.Suppl 5, p.16939, 2015. ,
DOI : 10.3947/ic.2013.45.4.351
The Treatment of Complicated and Uncomplicated Urinary Tract Infections with Temocillin, Drugs, vol.29, issue.Supplement 5, p.1724, 1985. ,
DOI : 10.2165/00003495-198500295-00036
Clinical Evaluation of Temocillin in Urinary Tract Infections, Drugs, vol.29, issue.Supplement 5, p.1757, 1985. ,
DOI : 10.2165/00003495-198500295-00037
Treatment of severe infections with temocillin. Clinical and bacteriological evaluation, Drugs, vol.29, p.2079, 1985. ,
Comparison of four commercial methods for determining temocillin susceptibility of Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.63, issue.4, p.8324, 2009. ,
DOI : 10.1093/jac/dkp035
Comparison of the Phoenix automated system, the Etest method and broth microdilution in determining temocillin susceptibility of Enterobacteriaceae, Journal of Antimicrobial Chemotherapy, vol.68, issue.7, p.16856, 2013. ,
DOI : 10.1093/jac/dkt049
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances, Nature Protocols, vol.217, issue.2, p.16375, 2008. ,
DOI : 10.1093/jac/48.suppl_1.5
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea, J Korean Med Sci. août, vol.29, issue.8, p.117881, 2014. ,
Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus, Diagnostic Microbiology and Infectious Disease, vol.65, issue.3, p.30611, 2009. ,
DOI : 10.1016/j.diagmicrobio.2009.07.012
Validation and Reproducibility Assessment of Tigecycline MIC Determinations by Etest, Journal of Clinical Microbiology, vol.45, issue.8, p.24749, 2007. ,
DOI : 10.1128/JCM.00089-07
Antimicrobial susceptilities of Temocillin and other agents against Enterobacteriaceae in Hong Kong. EPoster #P1275 présenté à: ECCMID 2017 ,
Temocillin: an alternative to carbapenem for multi-drug resistant Enterobacteriaceae. EPoster #EVO500 présenté à: ECCMID 2017 ,
témocilline, céfépime : sensibilité de 282 souches résistantes aux C3G. Poster P-008 présenté à: RICAI; 2016 déc ,
Témocilline et infections urinaires à EBLSE : diamètres d'inhibition, CMI. Poster PA-01 présenté à: RICAI; 2017 déc ,
Acitivité de la témocilline sur 92 entérobactéries productrices de BLSE, comparée à autres bêta-lactamines. Effet inoculum. RICAI; 2016 déc ,
Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations, Clinical Microbiology and Infection, vol.11, p.107, 2005. ,
DOI : 10.1111/j.1469-0691.2005.01265.x
Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections, Journal of Chemotherapy, vol.37, issue.1, p.259, 2017. ,
DOI : 10.3109/00365548.2011.553241
Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections, Journal of Antimicrobial Chemotherapy, vol.69, issue.9, p.251721, 2014. ,
DOI : 10.1093/jac/dku143
Temocillin susceptibility by BSAC methodology, Journal of Antimicrobial Chemotherapy, vol.60, issue.1, p.1857, 2007. ,
DOI : 10.1093/jac/dkm179
How does susceptibility prevalence impact on the performance of disk diffusion susceptibility testing?, Diagnostic Microbiology and Infectious Disease, vol.49, issue.2, p.1319, 2004. ,
DOI : 10.1016/j.diagmicrobio.2004.01.003
URL : https://hal.archives-ouvertes.fr/hal-00427611
ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.61, issue.5, 2017. ,
DOI : 10.1128/AAC.02313-16
Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women, JAMA, vol.283, issue.12, p.158390, 2000. ,
DOI : 10.1001/jama.283.12.1583
Complicated Urinary Tract Infection in Adults, Canadian Journal of Infectious Diseases and Medical Microbiology, vol.16, issue.6, p.34960, 2005. ,
DOI : 10.1155/2005/385768
A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis, Urology, vol.71, issue.1, p.1722, 2008. ,
DOI : 10.1016/j.urology.2007.09.002
Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: Impact of antimicrobial resistance in a large hospitalised cohort, Journal of Infection, vol.70, issue.3, p.24754, 2015. ,
DOI : 10.1016/j.jinf.2014.09.011
Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study, BMC Infectious Diseases, vol.60, issue.Suppl 3, p.639, 2014. ,
DOI : 10.1016/j.jinf.2009.11.008
Ertapenem versus Ceftriaxone Followed by Appropriate Oral Therapy for Treatment of Complicated Urinary Tract Infections in Adults: Results of a Prospective, Randomized, Double-Blind Multicenter Study, Antimicrobial Agents and Chemotherapy, vol.46, issue.9, p.2895900, 2002. ,
DOI : 10.1128/AAC.46.9.2895-2900.2002
Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy, Journal of Antimicrobial Chemotherapy, vol.53, issue.suppl_2, pp.67-74, 2004. ,
DOI : 10.1093/jac/dkh208
Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis, Journal of Antimicrobial Chemotherapy, vol.69, issue.4, p.88191, 2014. ,
DOI : 10.1093/jac/dkt477
Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis, International Journal of Antimicrobial Agents, vol.48, issue.1, p.110, 2016. ,
DOI : 10.1016/j.ijantimicag.2016.03.008
Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis, International Journal of Infectious Diseases, vol.16, issue.11, pp.768-773, 2012. ,
DOI : 10.1016/j.ijid.2012.07.010
Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficileassociated diarrhea: this is an antimicrobial resistance problem, Clin Infect Dis Off Publ Infect Dis Soc Am. 1 mars, vol.38, issue.5, p.6468, 2004. ,
An ecological and evolutionary perspective on human???microbe mutualism and disease, Nature, vol.44, issue.7164, p.8118, 2007. ,
DOI : 10.3201/eid1109.050124
Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance, Clinical Microbiology Reviews, vol.26, issue.2, p.289307, 2013. ,
DOI : 10.1128/CMR.00001-13
Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gramnegative pathogens among patients with hospital-onset urinary tract infections, Disponible sur, 5329905. ,
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens, Journal of Antimicrobial Chemotherapy, vol.67, issue.2, p.25568, 2012. ,
DOI : 10.1093/jac/dkr466
Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection, Antimicrobial Agents and Chemotherapy, vol.53, issue.10, p.42927, 2009. ,
DOI : 10.1128/AAC.01664-08
Restricting the Selection of Antibiotic???Resistant Mutants: A General Strategy Derived from Fluoroquinolone Studies, Clinical Infectious Diseases, vol.33, issue.s3, pp.147-156, 2001. ,
DOI : 10.1086/321841
Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms, International Journal of Antimicrobial Agents, vol.22, issue.2, p.95100, 2003. ,
DOI : 10.1016/S0924-8579(03)00232-2
Biological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.47, issue.9, p.28508, 2003. ,
DOI : 10.1128/AAC.47.9.2850-2858.2003
Quinoloneresistant Escherichia coli from the faecal microbiota of healthy volunteers after ciprofloxacin exposure are highly adapted to a commensal lifestyle, J Antimicrob Chemother. 1 mars, vol.69, issue.3, p.7618, 2014. ,
Amelioration of the Fitness Costs of Antibiotic Resistance Due To Reduced Outer Membrane Permeability by Upregulation of Alternative Porins, Molecular Biology and Evolution, vol.32, issue.12, p.325263, 2015. ,
DOI : 10.1093/molbev/msv195
Temocillin pharmokinetics in healthy volunteers after intravenous and subcutanous administration. EPoster #P1275 présenté à: ECCMID 2017 ,
Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime, Journal of Antimicrobial Chemotherapy, vol.69, issue.3, p.7869, 2014. ,
DOI : 10.1093/jac/dkt403
Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis, Journal of Hospital Infection, vol.78, issue.2, p.11822, 2011. ,
DOI : 10.1016/j.jhin.2011.03.008